Abstract
Over the last few decades it has become clear that depression can be effectively treated by elevating serotonergic and/or noradrenergic function in the brain. The close interplay between the ascending serotonergic pathways from the raphe and the ascending noradrenergic pathways from the locus coeruleus at both somatic and presynaptic sites makes it likely that both of these monoaminergic pathways will be altered by drugs acting selectively at enzymes or receptors of either one of these pathways. The role of 5-HT in the amelioration of unipolar depression has gained recent support with the introduction of the clinically effective selective serotonin reuptake inhibitors (SSRIs). However, a problem still unsolved by the introduction of the SSRIs is the slow onset of therapeutic effectiveness of all antidepressants of several weeks. Several lines of evidence suggest that this slow onset of action, particularly for the SSRIs, may be due to an inhibitory autoregulation of the serotonergic pathway after an elevation of synaptic 5-HT caused by activation of the somatodendritic 5-HT1A autoreceptor (Artigas et al.,1994; see Blier and Montigny, 1994). Larger increases in 5-HT than those achieved by the SSRIs may overcome some of the consequences of this inhibitory autoregulation and may therefore hasten the onset of therapeutic effect.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Artigas F., Perez V., and Alvarez E., 1994, Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors, Arch. Gen. Psychiat.51: 248.
Blier P. and de Montigny C., 1994, Current advances and trends in the treatment of depression, TIPS15: 220.
Heninger G.R., Delgado P.L., Charney D.S., Price L.H., and Aghajanian G.K., 1992, Tryptophan-deficient diet and amino acid drink deplete plasma tryptophan and induce a relapse of depression in susceptible patients, J. Chem. Neuroanat.5: 347.
Moller S.E., Kirk L., and Honore P., 1982, Tryptophan tolerance and metabolism in endogenous depression, Psychopharmacology76: 79.
Salter M., Knowles R.G., and Pogson C.I., 1986, Quantitation of the importance of individual steps in the control of aromatic amino acid metabolism, Biochem. J.234: 635.
Salter M., Hazelwood R., Pogson C.I., Iyer R., and Madge D.J., 1995, The effects of a novel and selective inhibitor of TDO on tryptophan and serotonin metabolism in the rat, Biochem. Pharmacol.49: 1435.
Salter M., Hazelwood R., Pogson C.I., Iyer R., Madge D.J., Jones H.T., Cooper B.R., Cox R.F., Wang C.M., and Wiard R.P., 1995, The effects of an inhibitor of TDO and a combined inhibitor of TDO and 5-HT reuptake in the rat, Neuropharmacology34: 217
Sharp T., Bramwell S.R., and Grahame-Smith D.G., 1992, Effect of acute administration of L-tryptophan on the release of 5-HT in rat hippocampus in relation to serotonergic neuronal activity: an in vivomicrodialysis study, Life Sci. 50: 1215.
Young S., 1991, Use of tryptophan in combination with other antidepressant treatments: a review, J. Psychiatr. Neurosci.16: 241
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Plenum Press, New York
About this chapter
Cite this chapter
Salter, M. et al. (1996). The Effects of a Selective Inhibitor of Tryptophan 2,3-Dioxygenase and a Combined Inhibitor of Tryptophan 2,3-Dioxygenase and 5-HT Reuptake on Serotonergic Function in the Rat. In: Filippini, G.A., Costa, C.V.L., Bertazzo, A. (eds) Recent Advances in Tryptophan Research. Advances in Experimental Medicine and Biology, vol 398. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0381-7_7
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0381-7_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-8026-9
Online ISBN: 978-1-4613-0381-7
eBook Packages: Springer Book Archive